Vaxcyte, Inc. (PCVX) stock
PCVXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$63.37−1.32 (-2.04%)
Close on Nov 13, 2026Market cap $9.43BP/E –Yield 0.00%
Vaxcyte market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Vaxcyte's market cap was $9.94B on Nov 11, 2026, against $6.45B a year earlier. Over the last 5 years it ranged from $1.00B to $12.64B, with a median of $4.92B.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $9.94B | +65.6% |
| 2025 | Dec 31, 2025 | $6.00B | -41.1% |
| 2024 | Dec 31, 2024 | $10.19B | +70.6% |
| 2023 | Dec 29, 2023 | $5.97B | +105.6% |
| 2022 | Dec 30, 2022 | $2.90B | +132.2% |
| 2021 | Dec 31, 2021 | $1.25B | -7.6% |
| 2020 | Dec 31, 2020 | $1.35B | – |
See a number that looks wrong?